{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T14:00:06Z","timestamp":1722952806959},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":517,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1111\/1469-0691.12169","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T11:10:59Z","timestamp":1360581059000},"page":"E291-E297","source":"Crossref","is-referenced-by-count":23,"title":["Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence"],"prefix":"10.1016","volume":"19","author":[{"given":"C.","family":"Forstner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dungl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tobudic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mitteregger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Lagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Burgmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12169_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/502522","article-title":"The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges","volume":"26","author":"Cosgrove","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/1469-0691.12169_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/0310057X0903700320","article-title":"Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteremia in critically ill patients: a case control study","volume":"37","author":"Ho","year":"2009","journal-title":"Anaesth Intensive Care"},{"key":"10.1111\/1469-0691.12169_bib3","author":"European Centre for Disease Prevention and Control"},{"key":"10.1111\/1469-0691.12169_bib4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3201\/eid1106.040831","article-title":"Methicillin-resistant Staphylococcus aureus hospitalizations, United States","volume":"11","author":"Kuehnert","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/1469-0691.12169_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10096-011-1310-2","article-title":"Factors influencing the clinical outcome of methicillin-resistant Staphylococcus aureus bacteraemia","volume":"31","author":"Albur","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12169_bib6","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/jac\/dkr301","article-title":"Site of infection rather than vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia","volume":"66","author":"Walraven","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12169_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2334-11-335","article-title":"The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus","volume":"11","author":"Honda","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1111\/1469-0691.12169_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets","volume":"52","author":"Kullar","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12169_bib9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in S. aureus infections: a systematic review and meta-analysis","volume":"54","author":"van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12169_bib10","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1086\/519471","article-title":"Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"45","author":"Micek","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12169_bib11","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1592\/phco.29.11.1275","article-title":"Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-Systems Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"29","author":"Rybak","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1111\/1469-0691.12169_bib12","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. MIC determination of nonfastidious and fastidious organisms \u2013 Broth microdilution methodology according to ISO and EUCAST. Version 2.0, May 2012."},{"key":"10.1111\/1469-0691.12169_bib13","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 2.0, valid from 2012-01-01"},{"key":"10.1111\/1469-0691.12169_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/CMR.05022-11","article-title":"Predictors of mortality in Staphylococcus aureus bacteremia","volume":"25","author":"van Hal","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/1469-0691.12169_bib15","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3201\/eid1807.101371","article-title":"Predicting risk of death from MRSA bacteremia","volume":"18","author":"Pastagia","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/1469-0691.12169_bib16","author":"Austrian Federal Ministry for Health"},{"issue":"Suppl 1","key":"10.1111\/1469-0691.12169_bib17","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42","author":"Levine","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12169_bib18","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/jac\/dkr169","article-title":"Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia","volume":"66","author":"Khatib","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12169_bib19","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/jac\/dks128","article-title":"Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients","volume":"67","author":"Rojas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12169_bib20","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jac\/dkn329","article-title":"Predictors of high vancomycin MIC values among patients with methicillin-resistant Staphylococcus aureus bacteraemia","volume":"62","author":"Lodise","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12169_bib21","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1128\/JCM.00775-12","article-title":"Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections","volume":"50","author":"Holmes","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12169_bib22","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jac\/dkr531","article-title":"Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study","volume":"67","author":"Chang","year":"2012","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14618504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14618504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T15:18:47Z","timestamp":1562685527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14618504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1198743X14618504"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12169","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}